Piccolo Medical

Piccolo Medical is a private, commercial-stage medtech company addressing a critical inefficiency in vascular access. With over 3 million PICC placements annually in the US, up to 50% are malpositioned without guidance, leading to complications and costly confirmatory chest x-rays. Piccolo's PM2+ and ECGuide systems provide real-time, bedside confirmation, offering hospitals a pathway to improved workflow, patient safety, and cost savings. The company appears to be in an early revenue phase, leveraging non-dilutive grant funding and building its commercial presence.

Integrated platform using Ionic Dilution technology for real-time catheter navigation and Intravascular ECG (IV ECG) for bedside tip confirmation, facilitated by a machine learning-enabled mobile app.

Piccolo competes in the vascular access guidance market against large incumbents like BD (Bard Access Systems) with its Sherlock 3CG® technology, which also uses IV ECG. Piccolo's key differentiation is its integrated ionic dilution technology for real-time navigation, which competitors lack, positioning it as offering a more comprehensive bedside solution.